
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study
Author(s) -
C.C. Dvorak,
P. Satwani,
E. Stieglitz,
M.S. Cairo,
H. Dang,
Q. Pei,
Y. Gao,
D. Wall,
T. Mazor,
A.B. Olshen,
J.S. Parker,
S. Kahwash,
B. Hirsch,
S. Raimondi,
N. Patel,
M. Skeens,
T. Cooper,
P.A. Mehta,
S.A. Grupp,
M.L. Loh
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/knfd-7v16
Subject(s) - juvenile myelomonocytic leukemia , juvenile , medicine , disease , oncology , randomized controlled trial , pediatrics , pediatric oncology , biology , cancer , genetics , stem cell , haematopoiesis